Abstract

Stevens-Johnson syndrome is generally self-limiting, vesiculobullous and an acute-onset disease in which at least two mucosal areas are affected in addition to skin lesions It results in mortality in 3-18% of severe cases. In etiology, especially drugs, a variety of infectious agents, malignancy, and collagen vascular disease play a role. Although there is no specific treatment, removing the disease-causing agent and supportive treatment are the first treatment to be applied. Moxifloxacin is a frequently-preferred fourth generation quinolone in the treatment of pneumonia. In this study, a case of Stevens-Johnson syndrome developing after the use of moxifloxacin is presented.